Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Deepali P. Sundrani, Aishwarya R. Karkhanis & Sadhana R. Joshi. (2021) Peroxisome Proliferator-Activated Receptors (PPAR), fatty acids and microRNAs: Implications in women delivering low birth weight babies.. Systems Biology in Reproductive Medicine 67:1, pages 24-41.
Read now
Read now
Articles from other publishers (22)
Yongmei Liu, Linlin Cheng, Haoting Zhan, Haolong Li, Xiaomeng Li, Yuan Huang & Yongzhe Li. (2022) The Roles of Noncoding RNAs in Systemic Sclerosis. Frontiers in Immunology 13.
Crossref
Crossref
Yifan Tai, Emma L. Woods, Jordanna Dally, Deling Kong, Robert Steadman, Ryan Moseley & Adam C. Midgley. (2021) Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis. Biomolecules 11:8, pages 1095.
Crossref
Crossref
Irene Soffritti, Maria D’Accolti, Gloria Ravegnini, Maria-Cristina Arcangeletti, Clara Maccari, Flora De Conto, Adriana Calderaro & Elisabetta Caselli. (2021) Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis. Cells 10:5, pages 1060.
Crossref
Crossref
Benjamin Thoreau, Benjamin Chaigne, Arthur Renaud & Luc Mouthon. (2021) Pathophysiology of systemic sclerosis. La Presse Médicale 50:1, pages 104087.
Crossref
Crossref
Asish K. Ghosh. (2020) Pharmacological activation of PPAR‐γ: a potential therapy for skin fibrosis. International Journal of Dermatology.
Crossref
Crossref
Yoshihide Asano & John Varga. (2020) Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategies. Seminars in Cell & Developmental Biology 101, pages 146-160.
Crossref
Crossref
Bianca Saveria Fioretto, Irene Rosa, Eloisa Romano, Yukai Wang, Serena Guiducci, Guohong Zhang, Mirko Manetti & Marco Matucci-Cerinic. (2020) The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2091845.
Crossref
Crossref
Pei-Suen Tsou. (2019) Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives. Current Rheumatology Reports 21:12.
Crossref
Crossref
Tyler W. Henry, Fabian A. Mendoza & Sergio A. Jimenez. (2019) Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy. Autoimmunity Reviews 18:11, pages 102396.
Crossref
Crossref
Paula S Ramos. (2019) Epigenetics of scleroderma: Integrating genetic, ethnic, age, and environmental effects. Journal of Scleroderma and Related Disorders 4:3, pages 238-250.
Crossref
Crossref
Jian Zhang, Qin Zhou, Hongtao Wang, Meiling Huang, Jihong Shi, Fu Han, Weixia Cai, Yan Li, Ting He & Dahai Hu. (2019) MicroRNA-130a has pro-fibroproliferative potential in hypertrophic scar by targeting CYLD. Archives of Biochemistry and Biophysics 671, pages 152-161.
Crossref
Crossref
Chiara Angiolilli, Wioleta Marut, Maarten van der Kroef, Eleni Chouri, Kris A. Reedquist & Timothy R. D. J. Radstake. (2018) New insights into the genetics and epigenetics of systemic sclerosis. Nature Reviews Rheumatology 14:11, pages 657-673.
Crossref
Crossref
Mirco Marco, Alice Ramassone, Sara Pagotto, Eleni Anastasiadou, Angelo Veronese & Rosa Visone. (2018) MicroRNAs in Autoimmunity and Hematological Malignancies. International Journal of Molecular Sciences 19:10, pages 3139.
Crossref
Crossref
Hai Long, Xin Wang, Yongjian Chen, Ling Wang, Ming Zhao & Qianjin Lu. (2018) Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets. Cancer Letters 428, pages 90-103.
Crossref
Crossref
Vanessa Castelli, Michele d'Angelo, Andrea Antonosante, Mariano Catanesi, Elisabetta Benedetti, Giovambattista Desideri & Annamaria Cimini. (2018) Physiology and Pathophysiology of PPARs in the Eye. Nuclear Receptor Research 5.
Crossref
Crossref
Pei-Suen Tsou & Amr H. Sawalha. (2017) Unfolding the pathogenesis of scleroderma through genomics and epigenomics. Journal of Autoimmunity 83, pages 73-94.
Crossref
Crossref
Gianluca Bagnato, William Neal Roberts, Jesse Roman & Sebastiano Gangemi. (2017) A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis. European Respiratory Review 26:144, pages 160125.
Crossref
Crossref
Bin Zhou, Honglin Zhu, Hui Luo, Siming Gao, Xiaodan Dai, Yisha Li & Xiaoxia Zuo. (2017) MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1. Biomedicine & Pharmacotherapy 87, pages 412-418.
Crossref
Crossref
Bin Zhou, Xiao Xia Zuo, Yi Sha Li, Si Ming Gao, Xiao Dan Dai, Hong Lin Zhu & Hui Luo. (2017) Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients. Scientific Reports 7:1.
Crossref
Crossref
Jianwei Tian, Liping Hu, Xiao Li, Jian Geng, Meng Dai & Xiaoyan Bai. (2016) RETRACTED ARTICLE: MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Xiaoyan Bai, Jian Geng, Zhanmei Zhou, Jianwei Tian & Xiao Li. (2016) MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy. Scientific Reports 6:1.
Crossref
Crossref
Thomas Bertero, Katherine A. Cottrill, Sofia Annis, Balkrishen Bhat, Bernadette R. Gochuico, Juan C. Osorio, Ivan Rosas, Kathleen J. Haley, Kathleen E. Corey, Raymond T. Chung, B. Nelson Chau & Stephen Y. Chan. (2015) A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions. Scientific Reports 5:1.
Crossref
Crossref